Viking Therapeutics, Inc.【VKTX】 純利益の推移
機能の使い方
|
（単位：千ドル）
|
純利益
|
前年比（％）
|
|
1Q25
|
-45,629
|
+66.8%
|
|
3Q24
|
-24,940
|
+10.7%
|
|
2Q24
|
-22,250
|
+15.7%
|
|
1Q24
|
-27,356
|
+40.1%
|
|
3Q23
|
-22,534
|
+42.9%
|
|
2Q23
|
-19,225
|
+10.3%
|
|
1Q23
|
-19,531
|
+21.3%
|
|
3Q22
|
-15,773
|
+19.1%
|
|
2Q22
|
-17,432
|
+13.3%
|
|
1Q22
|
-16,103
|
+14.9%
|
|
3Q21
|
-13,243
|
+42.6%
|
|
2Q21
|
-15,381
|
+60.7%
|
|
1Q21
|
-14,010
|
+44.6%
|
|
3Q20
|
-9,288
|
+62.1%
|
|
2Q20
|
-9,572
|
+24.7%
|
|
1Q20
|
-9,687
|
+96.7%
|
|
3Q19
|
-5,731
|
-13.2%
|
|
2Q19
|
-7,674
|
+15.0%
|
|
1Q19
|
-4,924
|
+38.7%
|
|
3Q18
|
-6,600
|
+8.2%
|
|
2Q18
|
-6,672
|
+29.0%
|
|
1Q18
|
-3,551
|
-32.0%
|
|
3Q17
|
-6,100
|
+60.2%
|
|
2Q17
|
-5,172
|
+40.0%
|
|
1Q17
|
-5,222
|
+45.6%
|
|
3Q16
|
-3,808
|
-19.6%
|
|
2Q16
|
-3,693
|
-53.0%
|
|
1Q16
|
-3,587
|
-37.2%
|
|
3Q15
|
-4,737
|
-
|
|
2Q15
|
-7,866
|
-
|
|
1Q15
|
-5,712
|
-
|